share_log

Cantor Fitzgerald Reiterates Overweight on AvePoint, Maintains $10 Price Target

Cantor Fitzgerald Reiterates Overweight on AvePoint, Maintains $10 Price Target

坎托·菲茨杰拉德重申增持 AvePoint,维持10美元的目标股价
Benzinga ·  2023/09/18 11:59

Cantor Fitzgerald analyst Brett Knoblauch reiterates AvePoint (NASDAQ:AVPT) with a Overweight and maintains $10 price target.

坎托·菲茨杰拉德分析师布雷特·诺布劳赫重申AvePoint(纳斯达克股票代码:AVPT)为增持,并维持10美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发